GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Serina Therapeutics Inc (AMEX:SER) » Definitions » Beginning Cash Position

SER (Serina Therapeutics) Beginning Cash Position : $3.24 Mil (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Serina Therapeutics Beginning Cash Position?

Serina Therapeutics's Beginning Cash Position for the quarter that ended in Dec. 2024 was $3.24 Mil.

Serina Therapeutics's quarterly Beginning Cash Position declined from Jun. 2024 ($8.76 Mil) to Sep. 2024 ($6.11 Mil) and declined from Sep. 2024 ($6.11 Mil) to Dec. 2024 ($3.24 Mil).

Serina Therapeutics's annual Beginning Cash Position increased from Dec. 2022 ($0.32 Mil) to Dec. 2023 ($0.53 Mil) and increased from Dec. 2023 ($0.53 Mil) to Dec. 2024 ($7.62 Mil).

Serina Therapeutics Beginning Cash Position Historical Data

The historical data trend for Serina Therapeutics's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Serina Therapeutics Beginning Cash Position Chart

Serina Therapeutics Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Beginning Cash Position
0.67 0.32 0.53 7.62

Serina Therapeutics Quarterly Data
Dec21 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.58 7.62 8.76 6.11 3.24

Serina Therapeutics Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Serina Therapeutics Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Serina Therapeutics's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Serina Therapeutics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Serina Therapeutics Inc (AMEX:SER) » Definitions » Beginning Cash Position
Comparable Companies
VTVT CYCC IKNA VICP NTRB CUE MAIA CTMX PDSB APLT VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
2BO:Germany
Address
601 Genome Way, Suite 2001, Huntsville, AL, USA, 35806
Website
https://www.serinatherapeutics.com
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.